Clinicopathological features and resistance mechanisms in HIP1-ALK-rearranged lung cancer: A multicenter study

Kang, J; Deng, QM; Peng, KC; Li, P; Zhu, BT; Wang, P; Chu, XP; Zhong, WZ; Chen, HJ; Wang, WX; Chen, HF; Rao, CZ; Xu, CW; Yang, JJ

Xu, CW (通讯作者)，Nanjing Univ, Affiliated Jinling Hosp, Med Sch, Dept Resp Med, 305 Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.;Yang, JJ (通讯作者)，Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, 106 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.

GENES CHROMOSOMES & CANCER, 2022; 61 (4): 177

Abstract

Anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) respond well to ALK tyrosine kinase inhibitors (TKIs), and echinoderm m......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索